BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 11997276)

  • 1. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction.
    Gibson CM; Cannon CP; Murphy SA; Marble SJ; Barron HV; Braunwald E;
    Circulation; 2002 Apr; 105(16):1909-13. PubMed ID: 11997276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group.
    Gibson CM; Murphy SA; Rizzo MJ; Ryan KA; Marble SJ; McCabe CH; Cannon CP; Van de Werf F; Braunwald E
    Circulation; 1999 Apr; 99(15):1945-50. PubMed ID: 10208996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction.
    Gibson CM; Murphy SA; Kirtane AJ; Giugliano RP; Cannon CP; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2004 Sep; 44(5):980-7. PubMed ID: 15337207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction.
    Gibson CM; Ryan KA; Murphy SA; Mesley R; Marble SJ; Giugliano RP; Cannon CP; Antman EM; Braunwald E
    J Am Coll Cardiol; 1999 Oct; 34(4):974-82. PubMed ID: 10520778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction.
    Gibson CM; Karha J; Giugliano RP; Roe MT; Murphy SA; Harrington RA; Green CL; Schweiger MJ; Miklin JS; Baran KW; Palmeri S; Braunwald E; Krucoff MW;
    Am Heart J; 2004 May; 147(5):847-52. PubMed ID: 15131541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
    Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
    Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.
    Gibson CM; Cannon CP; Murphy SA; Ryan KA; Mesley R; Marble SJ; McCabe CH; Van De Werf F; Braunwald E
    Circulation; 2000 Jan; 101(2):125-30. PubMed ID: 10637197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients.
    Gibson CM; Kirtane AJ; Boundy K; Ly H; Karmpaliotis D; Murphy SA; Giugliano RP; Cannon CP; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2005 Feb; 45(3):357-62. PubMed ID: 15680712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction.
    Gibson CM; Murphy SA; Morrow DA; Aroesty JM; Gibbons RJ; Gourlay SG; Barron HV; Giugliano RP; Antman EM; Braunwald E
    Am Heart J; 2004 Aug; 148(2):336-40. PubMed ID: 15309006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy.
    Gibson CM; Pride YB; Buros JL; Kunadian V; Southard MC; Harrigan CJ; Ciaglo LN; Sabatine MS; Cannon CP; Braunwald E
    Am J Cardiol; 2008 May; 101(9):1232-8. PubMed ID: 18435949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial.
    Murphy SA; Dauterman K; de Lemos JA; Kermgard S; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2003 Jul; 146(1):42-7. PubMed ID: 12851606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction.
    Gibson CM; Karha J; Murphy SA; de Lemos JA; Morrow DA; Giugliano RP; Roe MT; Harrington RA; Cannon CP; Antman EM; Califf RM; Braunwald E;
    J Am Coll Cardiol; 2004 Apr; 43(7):1170-6. PubMed ID: 15063425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.
    Brener SJ; Moliterno DJ; Aylward PE; van't Hof AW; Ruźyllo W; O'Neill WW; Hamm CW; Westerhout CM; Granger CB; Armstrong PW;
    Eur Heart J; 2008 May; 29(9):1127-35. PubMed ID: 18375399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial.
    Kanakakis J; Nanas JN; Tsagalou EP; Maroulidis GD; Drakos SG; Ntalianis AS; Tzoumele P; Skoumbourdis E; Charbis P; Rokas S; Anastasiou-Nana M
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):398-405. PubMed ID: 19360864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
    Karmpaliotis D; Turakhia MP; Kirtane AJ; Murphy SA; Kosmidou I; Morrow DA; Giugliano RP; Cannon CP; Antman EM; Braunwald E; Gibson CM;
    Am J Cardiol; 2004 Nov; 94(9):1113-7. PubMed ID: 15518603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction.
    French JK; Hyde TA; Straznicky IT; Andrews J; Lund M; Amos DJ; Zambanini A; Ellis CJ; Webber BJ; McLaughlin SC; Whitlock RM; Manda SO; Patel H; White HD
    J Am Coll Cardiol; 2000 May; 35(6):1516-24. PubMed ID: 10807455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction.
    Appelbaum E; Kirtane AJ; Clark A; Pride YB; Gelfand EV; Harrigan CJ; Kissinger KV; Manning WJ; Gibson CM
    J Thromb Thrombolysis; 2009 Feb; 27(2):123-9. PubMed ID: 18246410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators.
    Gibson CM; Cannon CP; Murphy SA; Adgey AA; Schweiger MJ; Sequeira RF; Grollier G; Fox NL; Berioli S; Weaver WD; Van de Werf F; Braunwald E
    Am J Cardiol; 1999 Nov; 84(9):976-80. PubMed ID: 10569649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.